Vanda Pharmaceuticals Inc. focuses on the development and commercialization of therapies to address high unmet medical needs.The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders. Its products under development include Fanapt (iloperidone) and Tradipitant (VLY-686) The company markets its products in the United States, Europe, and Israel.
